Selling Scholarship

T.V. Rajan's article "Cause Of Current Funding Crisis May Lie In De-emphasis Of Scholarship" [The Scientist, April 29, 1996, page 10] was informative and thought-provoking, but it had little to do with its title. Scholarship is as hard to sell as it is to define, and the personal inclinations or prerequisites for scholarship cannot be taught directly. Is it possible or desirable to educate just prospective Newtons and Einsteins? Of course, that is facetious, and there is a lot of room between N

Written byChristian Schwabe
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

T.V. Rajan's article "Cause Of Current Funding Crisis May Lie In De-emphasis Of Scholarship" [The Scientist, April 29, 1996, page 10] was informative and thought-provoking, but it had little to do with its title. Scholarship is as hard to sell as it is to define, and the personal inclinations or prerequisites for scholarship cannot be taught directly. Is it possible or desirable to educate just prospective Newtons and Einsteins? Of course, that is facetious, and there is a lot of room between Newtons and Einsteins and what we are educating today, often for the wrong reasons, I agree. We need both types of scholars-theoreticians and experimenters.

The symptoms of our establishment have been described clearly and accurately by Rajan, but he was too kind to volunteer the diagnosis. One could speak of surface blemishes extending into the core. Still we have made remarkable progress in science, so that critique will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies